磁振造影造影剂市场－全球产业规模、份额、趋势、机会和预测，依产品、类型、应用、最终用途、地区和竞争格局划分，2021-2031年预测

全球磁振造影（MRI）造影剂市场规模将从2025年的23.8亿美元成长至2031年的35.4亿美元，复合年增长率（CAGR）为6.84%。磁振造影（MRI）造影剂是一种特殊的化学物质，主要以钆为基础，透过静脉注射给药，以增强诊断扫描过程中体内结构的显影效果。这些造影剂能够改变附近水分子的磁性，进而提高影像清晰度，有助于检测肿瘤、血管异常和神经系统疾病。

主要市场驱动因素

政府对诊断影像设施的策略性投资，透过资助医疗基础设施现代化和扩大患者获得先进扫描服务的机会，显着促进了市场成长。世界各国政府都在拨出大量预算，以缩短诊断等待时间，并在医疗资源匮乏的地区安装最先进的磁振造影系统。

主要市场挑战

长期在体内组织中滞留钆的安全隐患是限制全球磁振造影造影剂市场发展的主要因素。这种担忧促使监管机构采取了严格的干预措施，导致更严格的给药方案，从而直接降低了增强磁振造影检查的频率和效率。

主要市场趋势

人工智慧在低剂量造影剂优化的应用正在革新市场，它能够以显着减少的造影剂用量实现诊断级成像。这一趋势利用深度学习演算法，从低剂量采集的影像中合成高解析度影像，有效解决了钆滞留这一关键安全隐患，从而有效地将影像清晰度与注射显影剂的用量解耦。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球磁振造影造影剂市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 副产物（超顺磁性试剂、顺磁性试剂）
  • 按类型（临床、临床前）
  • 依应用领域（胃肠道、静脉注射、肝胆、神经影像、其他）
  • 依最终用途（医院、影像中心）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美MRI造影剂市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲MRI造影剂市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区磁振造影显影剂市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲MRI造影剂市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲MRI造影剂市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球磁振造影造影剂市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• GE Healthcare Inc
• Bayer AG
• Guerbet GmbH
• Bracco Imaging Spa
• Vitalquan, LLC
• Miltenyi Biotec BV & Co. Kg

第十六章：策略建议

第17章调查会社について・免责事项

The Global MRI Contrast Media Agents Market will grow from USD 2.38 Billion in 2025 to USD 3.54 Billion by 2031 at a 6.84% CAGR. Magnetic Resonance Imaging (MRI) contrast media agents are specialized chemical substances, predominantly gadolinium-based, administered intravenously to enhance the visualization of internal body structures during diagnostic scans. These agents alter the magnetic properties of nearby water molecules to improve image clarity, facilitating the detection of tumors, vascular abnormalities, and neurological conditions.

Key Market Drivers

Strategic Government Investments in Diagnostic Imaging Facilities are significantly catalyzing market growth by funding the modernization of healthcare infrastructure and expanding patient access to advanced scans. Governments worldwide are allocating substantial budgets to reduce diagnostic wait times and install state-of-the-art MRI systems in underserved regions. This financial support directly translates into increased procurement of contrast media as new facilities become operational and scan volumes rise.

Key Market Challenges

Safety concerns regarding the long-term retention of gadolinium in body tissues constitute a primary restraint on the Global MRI Contrast Media Agents Market. This apprehension has necessitated rigorous regulatory interventions, leading to stricter administration protocols that directly reduce the frequency and efficiency of contrast-enhanced procedures. When regulatory bodies mandate extensive pre-screening for renal function or impose heightened safety warnings, imaging facilities face operational bottlenecks that decrease patient throughput.

Key Market Trends

Integration of AI for Low-Dose Contrast Optimization is revolutionizing the market by enabling diagnostic-quality imaging with significantly reduced volumes of contrast media. This trend addresses critical safety concerns regarding gadolinium retention by utilizing deep learning algorithms to synthesize high-resolution images from low-dose acquisitions, effectively decoupling image clarity from the volume of injected agent. This technological synergy not only mitigates potential toxicity risks for patients but also reduces consumable costs for healthcare facilities, driving the adoption of AI-enhanced radiology workflows.

Key Market Players

• GE Healthcare Inc
• Bayer AG
• Guerbet GmbH
• Bracco Imaging Spa
• Vitalquan, LLC
• Miltenyi Biotec B.V. & Co. Kg

Report Scope:

In this report, the Global MRI Contrast Media Agents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

MRI Contrast Media Agents Market, By Products:

• Superparamagnetic agents
• Paramagnetic agents

MRI Contrast Media Agents Market, By Type:

• Clinical
• Preclinical

MRI Contrast Media Agents Market, By Application:

• Gastrointestinal
• Intravenous
• Hepatobiliary
• Neurological Imaging
• Others

MRI Contrast Media Agents Market, By End Use:

• Hospitals
• Imaging Centers

MRI Contrast Media Agents Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global MRI Contrast Media Agents Market.

Available Customizations:

Global MRI Contrast Media Agents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global MRI Contrast Media Agents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Products (Superparamagnetic agents, Paramagnetic agents)
  • 5.2.2. By Type (Clinical, Preclinical)
  • 5.2.3. By Application (Gastrointestinal, Intravenous, Hepatobiliary, Neurological Imaging, Others)
  • 5.2.4. By End Use (Hospitals, Imaging Centers)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America MRI Contrast Media Agents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Products
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States MRI Contrast Media Agents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Products
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End Use
  • 6.3.2. Canada MRI Contrast Media Agents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Products
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End Use
  • 6.3.3. Mexico MRI Contrast Media Agents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Products
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End Use

7. Europe MRI Contrast Media Agents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Products
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany MRI Contrast Media Agents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Products
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End Use
  • 7.3.2. France MRI Contrast Media Agents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Products
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End Use
  • 7.3.3. United Kingdom MRI Contrast Media Agents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Products
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy MRI Contrast Media Agents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Products
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain MRI Contrast Media Agents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Products
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End Use

8. Asia Pacific MRI Contrast Media Agents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Products
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China MRI Contrast Media Agents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Products
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End Use
  • 8.3.2. India MRI Contrast Media Agents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Products
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End Use
  • 8.3.3. Japan MRI Contrast Media Agents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Products
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End Use
  • 8.3.4. South Korea MRI Contrast Media Agents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Products
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia MRI Contrast Media Agents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Products
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End Use

9. Middle East & Africa MRI Contrast Media Agents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Products
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia MRI Contrast Media Agents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Products
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End Use
  • 9.3.2. UAE MRI Contrast Media Agents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Products
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End Use
  • 9.3.3. South Africa MRI Contrast Media Agents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Products
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End Use

10. South America MRI Contrast Media Agents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Products
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil MRI Contrast Media Agents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Products
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End Use
  • 10.3.2. Colombia MRI Contrast Media Agents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Products
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End Use
  • 10.3.3. Argentina MRI Contrast Media Agents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Products
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global MRI Contrast Media Agents Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. GE Healthcare Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bayer AG
• 15.3. Guerbet GmbH
• 15.4. Bracco Imaging Spa
• 15.5. Vitalquan, LLC
• 15.6. Miltenyi Biotec B.V. & Co. Kg

16. Strategic Recommendations

17. About Us & Disclaimer